Profile
Thomas N.
Konatich was Vice President, Chief Financial Officer and Treasurer of SIGA Technologies, Inc. from April 1, 1998 to January 2009 and Secretary from June 29, 2001 to January 2009.
From 1993 to November 1996, he was Vice President and Chief Financial Officer of Seragen, Inc. From October 5, 2001 to July 2, 2004 and from May 1, 2006 to February 28, 2007, Mr. Konatich was an Acting Chief Executive Officer of SIGA Technologies and Chief Financial Officer and a Director of Innapharma, Inc. from November 1996 to March 1998.
He received an MBA from the Columbia Graduate School of Business.
Former positions of Thomas N. Konatich
Companies | Position | End |
---|---|---|
SIGA TECHNOLOGIES, INC. | Director of Finance/CFO | 2009-01-30 |
Innapharma, Inc. (New York)
Innapharma, Inc. (New York) Miscellaneous Commercial ServicesCommercial Services Part of TelMed, Inc., Innapharma, Inc. is a management consulting services company. The company is based in Suffern, NY. Innapharma, Inc. (New York) was acquired by TelMed, Inc. on June 26, 1996. | Director of Finance/CFO | 1998-02-28 |
Seragen, Inc.
Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million. | Director of Finance/CFO | 1996-10-31 |
Training of Thomas N. Konatich
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SIGA TECHNOLOGIES, INC. | Health Technology |
Private companies | 2 |
---|---|
Innapharma, Inc. (New York)
Innapharma, Inc. (New York) Miscellaneous Commercial ServicesCommercial Services Part of TelMed, Inc., Innapharma, Inc. is a management consulting services company. The company is based in Suffern, NY. Innapharma, Inc. (New York) was acquired by TelMed, Inc. on June 26, 1996. | Commercial Services |
Seragen, Inc.
Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million. | Health Technology |
- Stock Market
- Insiders
- Thomas N. Konatich